Submitted by: Submitted by sankp
Views: 10
Words: 472
Pages: 2
Category: Business and Industry
Date Submitted: 04/20/2016 01:31 AM
Viral Conjunctivitis Market Share, Size, Trends and Growth, Research Report and Forecasts, Pipeline Review, H1 2016
Global Markets Direct's, 'Viral Conjunctivitis - Pipeline Review, H1 2016', provides an overview of the Viral Conjunctivitis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Viral Conjunctivitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Viral Conjunctivitis and features dormant and discontinued projects.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/viral-conjunctivitis-pipeline-review-h1-2016
Scope
The report provides a snapshot of the global therapeutic landscape of Viral Conjunctivitis
The report reviews pipeline therapeutics for Viral Conjunctivitis by companies and universities/research institutes based on information derived from company and industry-specific sources
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
Table of Content
Table of Contents 2
List of Tables 4
Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/167932
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Viral Conjunctivitis Overview 6
Therapeutics Development 7
Pipeline Products for Viral Conjunctivitis - Overview 7
Viral Conjunctivitis - Therapeutics under...